Data sovereignty key navigating 340B's future helps healthcare leaders build integrated data systems for compliance and financial resilience in 2026.

The recent litigation concerning the government’s 340B Rebate Model Pilot Program (the Rebate Program), as further described ...

The American Hospital Association (AHA) expresses serious concerns with the recent announcement by Eli Lilly and Company (Lilly) to require 340B covered entities to submit claims data for all ...

HHS may reconsider blocked 340B rebate pilot after courts halt the program, signaling potential changes for drug discount policies in 2024.

The federal government has dropped its appeal of a preliminary injunction blocking implementation of the Department of Health ...

Sagebrush Health Services has filed a lawsuit against Amgen, alleging unlawful termination of discounted drug sales under the 340B Drug Pricing Program. The complaint claims Amgen bypassed federal ...

On January 7, 2026, the First Circuit Court of Appeals denied the federal government’s emergency motion to stay a district ...

The Trump administration has signaled plans to drop its appeal of a court order that blocked a pilot from changing payment terms for the 340B drug discount program.

A federal judge granted a temporary restraining order to block a pilot program aimed at keeping better tabs on the federal340B program.

Founded on pioneering research and industry leadership, ARxIUM® is committed to overcoming the most complex challenges ...

Health Affairs' Rob Lott interviews Sayeh Nikpay of the University of Minnesota about her recent paper exploring how The Medicaid Drug Rebate Program and the 340B Program interact in ways that can ...